摘要
Fungal keratitis, a severe infectious corneal disease, could lead to vision loss due to its uncontrolled progression and corneal damage. Current standard antifungal eye drops often fail in treatment, primarily due to poor ocular bioavailability from rapid tear clearance and limited corneal penetration. In this work, we developed a dual-drug-loaded microneedle (MN) patch featuring rapid effervescent detachment for targeted treatment of fungal keratitis. This MN patch comprises a methacrylated hyaluronic acid (MeHA) needle tip encapsulating amphotericin B (AmB), an effervescent middle layer loaded with voriconazole (VCZ) and poly(vinyl pyrrolidone) (PVP), and a supportive polystyrene (PS) backing, termed the MeHA-PVP-PS MN patch. When the MeHA-PVP-PS MN patch was inserted into the cornea, the effervescent reaction enabled the needle tips to detach rapidly within 15 s, which could minimize the contact time between the needle and the cornea. In vitro drug release tests, assessed via absorbance assays, revealed high drug loadings of AmB (52.98 ± 3.62 µg) and VCZ (198.54 ± 5.13 µg) in phosphate-buffered saline and anhydrous ethanol, respectively. In vivo rabbit pharmacokinetics analysis revealed elevated drug levels in the cornea and aqueous humor, with VCZ levels increased by more than 3-fold and AmB levels nearly doubled compared to conventional eye drops. In fungal keratitis rabbit models, eyes treated with MeHA-PVP-PS MN patch showed reduced inflammation, faster epithelial recovery, and lower clinical scores than the control group. Overall, the MeHA-PVP-PS MN patch enables rapid, minimally invasive dual-drug delivery, demonstrating the potential of microneedle-mediated intrastromal drug delivery for fungal keratitis treatment.
危险品化学品经营许可证(带存储)